Module

Tools for the Assessment of HBV Resistance in Clinical Practice

Source: Clinical Strategies for Preventing and Managing Resistance to Anti-HBV Agents

Tools for the Assessment of HBV Resistance in Clinical Practice

Faculty:
Fabien Zoulim, MD, PhD

CME CREDIT INFORMATION

Release Date: 04/14/06

Expiration Date: 04/13/07

Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Discuss viral load monitoring in chronic hepatitis B patients
Summarize the development of HBV drug resistance
Describe strategies to monitor drug resistance evolution in chronic HBV infection

Topics covered include:

HBV DNA
Viral Load Monitoring
Viral Resistance
Predictive factors of resistance
Monitoring drug resistance

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.